How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?
Yıl: 2021 Cilt: 22 Sayı: 2 Sayfa Aralığı: 149 - 153 Metin Dili: İngilizce DOI: 10.5152/TurkThoracJ.2021.20249 İndeks Tarihi: 08-12-2021
How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?
Öz: JECTIVE: This study aimed to focus on non-COVID-19 patients during the process when all physicians focused on COVID-19 patients.Patients with pulmonary diseases in the COVID-19 pandemic period were analyzed. MATERIAL AND METHODS: Non-COVID-19 cases who were hospitalized in the pulmonology clinic, outpatients, and patients whoapplied to the non-COVID-19 emergency service and requested a pulmonology consultation in the period from March 16, 2020 to May15, 2020 and in the same period of the previous year (i.e., from March 16, 2019 to May 15, 2019) were included in this study. RESULTS: In the pandemic period, it was found that there was an 84% decrease in outpatient admissions, a 43% decrease in inpatients,and a 75% decrease in emergency services. During the pandemic period, in outpatient setting, male and younger case admissions in creased, admissions with chronic obstructive pulmonary disease (COPD), and interstitial lung diseases decreased, whereas the frequencyof admission to asthma, pneumonia, and pulmonary thromboembolism increased. In the period of the pandemic, patients with asthma,COPD, and lung cancer were less hospitalized, whereas patients with pulmonary thromboembolism, pneumonia, and pleural effusionwere hospitalized more. In non-COVID-19 patient treatments during the pandemic period, usage of a metered dose inhaler increased.CONCLUSION: During the COVID-19 pandemic, non-COVID pulmonary pathologies decreased significantly, and there was a changein the profile of the patients. From now on, to be prepared for pandemic and similar extraordinary situations, to organize hospitals for theepidemic, to determine health institutions to which nonepidemic patients can apply, to make necessary plans in order not to neglect thenonepidemic patients, and to develop digital health service methods, especially telemedicine, would be appropriate.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
- 1. Baloch S, Baloch MA, Zheng T, Pei X. The coronavirus disease 2019 (COVID-19) pandemic. Tohoku J Exp Med 2020;250:271- 8. [CrossRef]
- 2. Majersik JJ, Reddy VK. Acute neurology during the COVID-19 pandemic: supporting the front line. Neurology 2020;94:1055- 7. [CrossRef]
- 3. Hart JL, Turnbull AE, Oppenheim IM, Courtright KR. FamilyCentered Care During the COVID-19 Era. J Pain Symptom Manage 2020;60:e93-e7. [CrossRef]
- 4. Prachand VN, Milner R, Angelos P, et al. Medically necessary, timesensitive procedures: scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic. J Am Coll Surg 2020;231:281-8. [CrossRef]
- 5. Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm 2021;17:2023-6. [CrossRef]
- 6. Block BL, Smith AK, Sudore RL. During COVID-19, outpatient advance care planning is imperative: we need all hands on deck. J Am Geriatr Soc 2020;68:1395-7. [CrossRef]
- 7. Weller M, Preusser M. How we treat patients with brain tumour during the COVID-19 pandemic. ESMO Open 2020;4:e000789. [CrossRef]
- 8. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020;75:2352-71. [CrossRef]
- 9. Mehra MR, Desai SS, Kuy SR, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med 202;382:e102. [CrossRef]
- 10. Keny S, Bagaria V, Chaudhary K, Dhawale A. Emergency and urgent orthopaedic surgeries in non-covid patients during the COVID 19 pandemic: perspective from India. J Orthop 2020;20:275-9. [CrossRef]
- 11. Silverman DA, Lin C, Tamaki A, et al. Respiratory and pulmonary complications in head and neck cancer patients: evidencebased review for the COVID-19 era. Head Neck 2020;42:1218- 26. [CrossRef]
- 12. Eke OF, Morone CC, Liteplo AS, Shokoohi H. Non-Covid-19 clinical research in the era of pandemic. Am J Emerg Med 2021;39:231-2. [CrossRef]
- 13. Republic of Turkey, Ministry of Health data. 2020. Available at: https://covid19bilgi.saglik.gov.tr/tr/haberler/turkiye-deki-gunluk-covid-19-vaka-sayilari.html.
- 14. Elson EC, Oermann C, Duehlmeyer S, Bledsoe S. Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic. Am J Health Syst Pharm 2020;77:1005- 6. [CrossRef]
- 15. Ateev Mehrotra et al., “The Impact of the COVID-19 Pandemic on Outpatient Visits: A Rebound Emerges,” To the Point (blog), Commonwealth Fund, May 19, 2020. https://doi.org/10.26099/ ds9e-jm36
- 16. Masroor S. Collateral damage of COVID-19 pandemic: delayed medical care. J Card Surg 2020;35:1345-7. [CrossRef]
- 17. Comelli I, Scioscioli F, Cervellin G. Impact of the COVID-19 epidemic on census, organization and activity of a large urban emergency department. Acta Biomed. 2020;91:45-9. [CrossRef]
- 18. Poyiadi N, Cormier P, Patel PY, et al. Acute pulmonary embolism and COVID-19. Radiology 2020;297:E335-E8. [CrossRef]
- 19. Wahidi MM, Shojaee S, Lamb CR, et al. The use of bronchoscopy during the coronavirus disease 2019 pandemic: CHEST/ AABIP guideline and expert panel report. Chest 2020;158:1268- 81. [CrossRef]
- 20. Luo F, Darwiche K, Singh S, et al. Performing Bronchoscopy in Times of the COVID-19 Pandemic: Practice Statement from an International Expert Panel. Respiration 2020. [CrossRef]
- 21. Steinfort DP, Herth FJF, Irving LB, Nguyen PT. Safe performance of diagnostic bronchoscopy/EBUS during the SARS-CoV-2 pandemic. Respirology 2020;25:703-8. [CrossRef]
- 22. Mantica G, Riccardi N, Terrone C, Gratarola A. Non-COVID-19 visits to emergency services during the pandemic: the impact of fear. Public Health 2020;183: 40-1.
- 23. Hartnett KP, Kite-Powell A, DeVies J, et al. Impact of the COVID-19 Pandemic on Emergency service Visits- United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:699-704. [CrossRef]
APA | Sevinc C, Tertemiz K, Demirci Atik M, Güler N, ULUSOY M, Coskun F, Uyar N, Ellidokuz H, İTİL O, CİMRİN A, Uçan E (2021). How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. , 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
Chicago | Sevinc Can,Tertemiz Kemal Can,Demirci Atik Merve,Güler Nurcan,ULUSOY Mustafa,Coskun Figen,Uyar Nezihe,Ellidokuz Hülya,İTİL Oya,CİMRİN Arif Hikmet,Uçan Eyüp Sabri How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. (2021): 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
MLA | Sevinc Can,Tertemiz Kemal Can,Demirci Atik Merve,Güler Nurcan,ULUSOY Mustafa,Coskun Figen,Uyar Nezihe,Ellidokuz Hülya,İTİL Oya,CİMRİN Arif Hikmet,Uçan Eyüp Sabri How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. , 2021, ss.149 - 153. 10.5152/TurkThoracJ.2021.20249 |
AMA | Sevinc C,Tertemiz K,Demirci Atik M,Güler N,ULUSOY M,Coskun F,Uyar N,Ellidokuz H,İTİL O,CİMRİN A,Uçan E How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. . 2021; 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
Vancouver | Sevinc C,Tertemiz K,Demirci Atik M,Güler N,ULUSOY M,Coskun F,Uyar N,Ellidokuz H,İTİL O,CİMRİN A,Uçan E How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. . 2021; 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
IEEE | Sevinc C,Tertemiz K,Demirci Atik M,Güler N,ULUSOY M,Coskun F,Uyar N,Ellidokuz H,İTİL O,CİMRİN A,Uçan E "How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?." , ss.149 - 153, 2021. 10.5152/TurkThoracJ.2021.20249 |
ISNAD | Sevinc, Can vd. "How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?". (2021), 149-153. https://doi.org/10.5152/TurkThoracJ.2021.20249 |
APA | Sevinc C, Tertemiz K, Demirci Atik M, Güler N, ULUSOY M, Coskun F, Uyar N, Ellidokuz H, İTİL O, CİMRİN A, Uçan E (2021). How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. Turkish Thoracic Journal, 22(2), 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
Chicago | Sevinc Can,Tertemiz Kemal Can,Demirci Atik Merve,Güler Nurcan,ULUSOY Mustafa,Coskun Figen,Uyar Nezihe,Ellidokuz Hülya,İTİL Oya,CİMRİN Arif Hikmet,Uçan Eyüp Sabri How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. Turkish Thoracic Journal 22, no.2 (2021): 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
MLA | Sevinc Can,Tertemiz Kemal Can,Demirci Atik Merve,Güler Nurcan,ULUSOY Mustafa,Coskun Figen,Uyar Nezihe,Ellidokuz Hülya,İTİL Oya,CİMRİN Arif Hikmet,Uçan Eyüp Sabri How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. Turkish Thoracic Journal, vol.22, no.2, 2021, ss.149 - 153. 10.5152/TurkThoracJ.2021.20249 |
AMA | Sevinc C,Tertemiz K,Demirci Atik M,Güler N,ULUSOY M,Coskun F,Uyar N,Ellidokuz H,İTİL O,CİMRİN A,Uçan E How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. Turkish Thoracic Journal. 2021; 22(2): 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
Vancouver | Sevinc C,Tertemiz K,Demirci Atik M,Güler N,ULUSOY M,Coskun F,Uyar N,Ellidokuz H,İTİL O,CİMRİN A,Uçan E How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?. Turkish Thoracic Journal. 2021; 22(2): 149 - 153. 10.5152/TurkThoracJ.2021.20249 |
IEEE | Sevinc C,Tertemiz K,Demirci Atik M,Güler N,ULUSOY M,Coskun F,Uyar N,Ellidokuz H,İTİL O,CİMRİN A,Uçan E "How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?." Turkish Thoracic Journal, 22, ss.149 - 153, 2021. 10.5152/TurkThoracJ.2021.20249 |
ISNAD | Sevinc, Can vd. "How were Non-COVID pulmonary patients and diseasesaffected from COVID-19 pandemic period?". Turkish Thoracic Journal 22/2 (2021), 149-153. https://doi.org/10.5152/TurkThoracJ.2021.20249 |